Page last updated: 2024-10-27

fenofibrate and Cancer of Endometrium

fenofibrate has been researched along with Cancer of Endometrium in 2 studies

Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE

Research Excerpts

ExcerptRelevanceReference
"A nude mouse model of endometrial carcinoma was used to investigate the effect of fenofibrate in vivo but failed to show consistent inhibition of tumour growth."1.33In vitro and in vivo effects of the PPAR-alpha agonists fenofibrate and retinoic acid in endometrial cancer. ( Charnock-Jones, DS; Holland, CM; Saidi, SA; Smith, SK, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Miao, C1
Chen, Y1
Fang, X1
Zhao, Y1
Wang, R1
Zhang, Q1
Saidi, SA1
Holland, CM1
Charnock-Jones, DS1
Smith, SK1

Other Studies

2 other studies available for fenofibrate and Cancer of Endometrium

ArticleYear
Identification of the shared gene signatures and pathways between polycystic ovary syndrome and endometrial cancer: An omics data based combined approach.
    PloS one, 2022, Volume: 17, Issue:7

    Topics: Computational Biology; Endometrial Neoplasms; Female; Fenofibrate; Gene Regulatory Networks; Humans;

2022
In vitro and in vivo effects of the PPAR-alpha agonists fenofibrate and retinoic acid in endometrial cancer.
    Molecular cancer, 2006, Mar-28, Volume: 5

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Dose-Res

2006